| 000 | 01693 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515173714.0 | ||
| 264 | 0 | _c20090706 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1421-9662 | ||
| 024 | 7 |
_a10.1159/000214856 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichiels, Jan Jacques | |
| 245 | 0 | 0 |
_aDominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management. _h[electronic resource] |
| 260 |
_bActa haematologica _c2009 |
||
| 300 |
_a154-66 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aADAM Proteins _xmetabolism |
| 650 | 0 | 4 | _aADAMTS13 Protein |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 | _aBlood Protein Electrophoresis |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 |
_aDeamino Arginine Vasopressin _xtherapeutic use |
| 650 | 0 | 4 |
_aExons _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xblood |
| 650 | 0 | 4 | _aProtein Structure, Quaternary |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_avon Willebrand Diseases _xclassification |
| 650 | 0 | 4 |
_avon Willebrand Factor _xanalysis |
| 700 | 1 | _avan Vliet, Huub H D M | |
| 773 | 0 |
_tActa haematologica _gvol. 121 _gno. 2-3 _gp. 154-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000214856 _zAvailable from publisher's website |
| 999 |
_c18929823 _d18929823 |
||